维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Iorns E"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Utilizing RNA interference to enhance cancer drug discovery显示文摘	Iorns E Lord C J Turner N	2007	Nat Rev Drug Discov2007，6，7：	1
2	Identification of CDKIO as an important determinant of resistance to endocrine therapy for breast cancer显示文摘	Iorns E Turner NC Elliott R	2008	Cancer Cell2008，13，2：	1
3	Dissecting resistance to endocrine therapy in breast cancer显示文摘	Lord C J Iorns E Ashworth A	2008	Cell Cycle2008，7，13：	1
4	Integrated func-tional,gene expression and genomic analysis for the identification of cancer targets显示文摘	IORNS E LORD C J GRIGORIADIS A	2009	PLoS One2009，4，4：	1
5	PI3K independent activation of mTORC1 as a target in lapatinib- resistant ERBB2+ breast cancer cells显示文摘	Jegg A Ward TM Iorns E	2012	Breast Cancer Res Treat2012，136，3：	1
6	Identi?cation of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer显示文摘	Iorns E Tumer NC Elliott R	2008	Cancer Ce112008，13，2：	1
7	Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer显示文摘	Iorns E Turner NC Elliott R	2008	Cancer Cell2008，13，2：	1
8	Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer 显示文摘	IORNS E TURNER NC ELLIOTT R	2008	Cancer Cell2008，13，：	1
9	A new mouse model for the study of human breast cancer metastasis显示文摘	Iorns E Drews-Elger K Ward TM	2012	PLoS One2012，7，47：	1
10	Utilizing RNA interference to enhance cancer drug discovery显示文摘	Iorns E Lord GJ Turner N	2007	Nat Rev Drug Discov2007，6，7：	1
11	An open investigation of the reproducibility of cancer biology research 显示文摘	Errington TM Iorns E Gunn W	2014	eLife2014，3，04：	1
12	The role of SATB1 in breast cancer pathogenesis 显示文摘	Iorns E Hnatyszyn H J Seo P	2010	J Natl Cancer Inst2010，102，16：	1
13	Identification of CDKIO as an important determinant of resistance to endocrine therapy for breast cancer 显示文摘	Iorns E Turner N C Elliott R	2008	CancerCell2008，13，：	1
14	Parallel RNAi and compound screens identify the PDK1pathway as a target for tamoxifen sensitization显示文摘	Iorns E Lord CJ Ashworth A	2009	Biochem J2009，417，1：	1
15	Utilizing RNA interference to enhance cancer drug discovery显示文摘	IORNS E LORD C J TUNER N	2007	Nat Rev Drug Discov2007，6，7：	1
16	A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor显示文摘	Turner NC Lord CJ Iorns E Brough R Swift S Elliott R	2008	EMBO J2008，27，9：	1
17	Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer显示文摘	Iorns E Turner NC Elliott R	2009	Cancer Cell2009，13，2：	1
18	Utilizing RNA interference to enhance cancer drug discovery显示文摘	IORNS E LORD C J TURNER N	2007	Nat Rev Drug Discov2007，6，：	1
19	P13K independent activation of m TORCI as a target in lapatinib-resistant ERBB2+breast cancer cells显示文摘	Jegg AM Ward TM Iorns E	2012	Breast Cancer Res Treat2012，136，3：	1
20	Utilizing RNA interference to enhance cancer drug discovery显示文摘	IORNS E LORD C J TURNER N	2007	Nat Rev Drug Discov2007，6，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示